STIM
Neuronetics Inc
2.90$
-1.0%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 76.4% | 81.0% | 78.9% | 78.0% | 72.1% | 41.2% | 42.7% | 41.7% | 44.6% | 43.5% | 37.6% | 40.5% | |
| 38.6% | 51.5% | 46.0% | 44.0% | 28.2% | 13.8% | 14.9% | 13.0% | 23.7% | 24.1% | 10.5% | 14.6% | |
| 39.6% | 52.3% | 46.8% | 44.8% | 28.9% | 14.0% | 15.1% | 13.1% | 23.8% | 24.3% | 10.5% | 14.8% | |
| 18.1% | 15.4% | 18.9% | 20.1% | 26.0% | 17.2% | 18.9% | 19.8% | 13.2% | 11.9% | 12.8% | 12.4% | |
| 10.5% | 7.0% | 6.4% | 6.3% | 6.7% | 3.0% | 2.9% | 3.7% | 3.0% | 3.1% | 3.8% | 4.2% | |
| – | 0.0% | – | – | – | 13.2% | 13.1% | 14.2% | 15.6% | 16.7% | 18.8% | 18.0% | |
| – | 3.6% | – | – | – | 13.9% | 13.6% | 14.0% | 13.1% | 12.8% | 14.2% | 13.2% | |
| 59.2% | 70.5% | 73.4% | 80.0% | 87.3% | 77.4% | 72.2% | 76.6% | 78.4% | 81.5% | 86.4% | 83.5% | |
| 16.5% | 17.1% | 14.0% | 30.2% | 22.8% | 22.2% | 17.5% | 20.6% | 19.9% | 21.6% | 22.5% | 21.5% | |
| 0.9% | 0.7% | 0.8% | 14.9% | 1.2% | 3.4% | 3.5% | 3.9% | 3.8% | 3.9% | 4.3% | 3.9% | |
| 3.0% | 4.1% | 2.9% | 4.2% | 4.4% | 7.9% | 6.0% | 7.2% | 8.0% | 7.6% | 9.1% | 9.4% | |
| 39.6% | 51.2% | 57.3% | 47.7% | 62.1% | 39.1% | 39.0% | 41.2% | 45.1% | 46.5% | 48.9% | 46.8% | |
| 40.8% | 29.5% | 26.6% | 20.0% | 12.7% | 19.7% | 25.0% | 20.2% | 18.8% | 15.8% | 10.6% | 13.6% | |
| -398.7% | -324.7% | -369.9% | -406.7% | -549.3% | -297.9% | -304.6% | -328.7% | -310.5% | -324.1% | -374.3% | -359.7% | |
| 31.1% | 25.1% | 28.4% | 31.0% | 40.8% | 26.0% | 43.3% | 49.1% | 46.3% | 48.6% | 55.5% | 54.3% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.